Skip to main content
. 2020 Nov 13;9(11):805. doi: 10.3390/antibiotics9110805

Table 2.

Oligonucleotides a.

Name Nucleotide Sequence b Notes
ARP261 TAACGCTTCACTCGAGGCGTTTTTCGTTATGTATAAAAAGGAGCACACC/ATGGCTAACGTAATTAAAACCGTTTTGACTTACCAG λ pL g17 forward oligo
ARP262 GCTTCCCAGCCAGCGTTGCGAGTGCAGTACTCATTCGTTTTATACCTCTG/ATTACTCGTTCTCCACCATGATTGCATTAGG λ pL g17 reverse oligo
ARP292 ACCAGAACTCATGGCAAGCACGTAATGAAGCCTTA
CAGTTCCGTAATGAGGCTGAGACTTTCAGAAACCAA
T7 g17Q170UAG-CAG leading strand oligo
ARP293 TTGGTTTCTGAAAGTCTCAGCCTCATTACGGAA
CTGTAAGGCTTCATTACGTGCTTGCCATGAGTTCTGGT
T7 g17Q170UAG-CAG lagging strand oligo
ARP301 GGCAGTGACCCGCTTCCCGTTCGTCCGTCTGTTACTCAAACGAATCAAGGAGGTGTTCTG/ATGAGCGATAAAATTATTCACCTGACTGAC T7 g1.7<>trxA forward
ARP302 CACTCTGAGCAAGATGTGAAGTCATCAGATAGGCTGTCGGCAGGTGGGGTTGACTTGAAG/TTACGCCAGGTTAGCGTCGAGGA T7 g1.7<>trxA reverse
ARP309 ACCAACACGCCAGGCTTATTCCTGTGGAGTTATAT/TCCTAATTTTTGTTGACACTCTATC trxA<>tetA forward
ARP310 TTTTTAGCGACGGGGCACCCGAACATGAAATTCCC/ATCAAAGGGAAAACTGTCCATATGC trxA<>tetA reverse
ARP321 ACCAGAACTCATGGCAAGCACGTAATGAAGC g17am267 70 bp dsDNA forward
ARP322 CGCTTGGTTTCTGAAAGTCTCAGCCTCATTACGG g17am267 70 bp dsDNA forward
ARP356 CGAAATAATCTTCTCCCTGTAGTCTCTTAGATTTACTTTAAGGAGGTCAA/ATGAGCGATAAAATTATTCACCTGACTGAC g17<>trxA forward
ARP357 AGGTACAGTCATTGTTGTTATCTGACCCTCTACCAATGTACCAGTTATTC/TTACGCCAGGTTAGCGTCGAGGA g17<>trxA reverse

a Oligos were obtained desalted from Integrated DNA Technologies in Coralville, IA. b “/” indicates the border between 5′ homology to recombineering targets and 3′ homology used for primer PCR. The underlined CAG or CTG are the codon positions in the oligos ARP292 and ARP293 that correct the amber mutation in g17 used in these studies.